Pharma Dynamics founder to step down as CEO

BY SUPPLIED - SEPTEMBER 22, 2015

Pharma Dynamics founder, Paul Anley, will be handing over the chief executive reins of one of SA’s fastest growing pharmaceutical firms to industry-veteran Erik Roos, former CEO of Mylan South Africa.

 Anley, who started Pharma Dynamics in 2001, has driven the company’s meteoric rise to national recognition and prominence. Pharma Dynamics is now SA’s biggest distributor of cardiovascular medicine, and ranks as the fourth largest generic pharmaceutical company in the country.

 Following the full purchase of the company in April this year by the Lupin Group, India’s third largest pharmaceutical company by total sales, Anley will step down as Director and CEO at the end of March 2016. 

 Erik Roos has been appointed as CEO designate of Pharma Dynamics with effect from 1 November 2015 and will work closely with Anley in the upcoming months to ensure a smooth handover.

 Commenting on the announcement, Anley said Pharma Dynamics is ideally positioned to continue the sales momentum into the next phase of its growth.

 “The company has an experienced management team, an extensive and strong sales force, an enviable brand image and corporate reputation. This, combined with what could be the largest product pipeline in the industry, will ensure its continued success,” concluded Anley.

Image sourced: heartrecipes.mobi